{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:04:16Z","timestamp":1771913056747,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Agreement concerning research and education of doctors (ALF\/LUA grant), Swedish federal government"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12933-016-0353-1","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T02:29:09Z","timestamp":1455848949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Insulin resistance, endothelial function, angiogenic factors and clinical outcome in non-diabetic patients with chest pain without myocardial perfusion defects"],"prefix":"10.1186","volume":"15","author":[{"given":"Helena U.","family":"Westergren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Svedlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remi A.","family":"Momo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juuso I.","family":"Blomster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"W\u00e5hlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Rehnstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Greasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Fritsche-Danielson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Oscarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6687-8743","authenticated-orcid":false,"given":"Li-Ming","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,19]]},"reference":[{"issue":"6 Pt 1","key":"353_CR1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0002-8703(99)70066-9","volume":"138","author":"X Kang","year":"1999","unstructured":"Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germano G, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J. 1999;138(6 Pt 1):1025\u201332.","journal-title":"Am Heart J"},{"issue":"5","key":"353_CR2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.CIR.93.5.905","volume":"93","author":"R Hachamovitch","year":"1996","unstructured":"Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 1996;93(5):905\u201314.","journal-title":"Circulation"},{"issue":"24","key":"353_CR3","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"SD Fihn","year":"2012","unstructured":"Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines, and the American College of Physicians, American Association for thoracic surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):e44\u2013164. doi: 10.1016\/j.jacc.2012.07.013 .","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"353_CR4","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"M Task Force","year":"2013","unstructured":"Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949\u20133003. doi: 10.1093\/eurheartj\/eht296 .","journal-title":"Eur Heart J"},{"issue":"6","key":"353_CR5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","volume":"33","author":"L Jespersen","year":"2012","unstructured":"Jespersen L, Hvelplund A, Abildstrom SZ, Pedersen F, Galatius S, Madsen JK, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734\u201344. doi: 10.1093\/eurheartj\/ehr331 .","journal-title":"Eur Heart J"},{"issue":"7","key":"353_CR6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacc.2011.11.015","volume":"59","author":"P Ong","year":"2012","unstructured":"Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012;59(7):655\u201362. doi: 10.1016\/j.jacc.2011.11.015 .","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"353_CR7","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jamainternmed.2014.3773","volume":"174","author":"PG Steg","year":"2014","unstructured":"Steg PG, Greenlaw N, Tendera M, Tardif JC, Ferrari R, Al-Zaibag M, et al. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. JAMA Intern Med. 2014;174(10):1651\u20139. doi: 10.1001\/jamainternmed.2014.3773 .","journal-title":"JAMA Intern Med"},{"issue":"11","key":"353_CR8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","volume":"8","author":"JD Sara","year":"2015","unstructured":"Sara JD, Widmer RJ, Matsuzawa Y, Lennon RJ, Lerman LO, Lerman A. Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc Interv. 2015;8(11):1445\u201353. doi: 10.1016\/j.jcin.2015.06.017 .","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"353_CR9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10554-014-0492-y","volume":"30","author":"M Ponte","year":"2014","unstructured":"Ponte M, Bettencourt N, Pereira E, Ferreira ND, Chiribiri A, Schuster A, et al. Anatomical versus functional assessment of coronary artery disease: direct comparison of computed tomography coronary angiography and magnetic resonance myocardial perfusion imaging in patients with intermediate pre-test probability. Int J Cardiovasc Imaging. 2014;30(8):1589\u201397. doi: 10.1007\/s10554-014-0492-y .","journal-title":"Int J Cardiovasc Imaging"},{"issue":"3","key":"353_CR10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCINTERVENTIONS.108.841056","volume":"2","author":"A Cassar","year":"2009","unstructured":"Cassar A, Chareonthaitawee P, Rihal CS, Prasad A, Lennon RJ, Lerman LO, et al. Lack of correlation between noninvasive stress tests and invasive coronary vasomotor dysfunction in patients with nonobstructive coronary artery disease. Circ Cardiovasc Interv. 2009;2(3):237\u201344. doi: 10.1161\/CIRCINTERVENTIONS.108.841056 .","journal-title":"Circ Cardiovasc Interv"},{"key":"353_CR11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2015.04.124","volume":"190","author":"Y Matsuzawa","year":"2015","unstructured":"Matsuzawa Y, Svedlund S, Aoki T, Guddeti RR, Kwon TG, Cilluffo R, et al. Utility of both carotid intima-media thickness and endothelial function for cardiovascular risk stratification in patients with angina-like symptoms. Int J Cardiol. 2015;190:90\u20138. doi: 10.1016\/j.ijcard.2015.04.124 .","journal-title":"Int J Cardiol"},{"issue":"1","key":"353_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","volume":"12","author":"PG Camici","year":"2015","unstructured":"Camici PG, d\u2019Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol. 2015;12(1):48\u201362. doi: 10.1038\/nrcardio.2014.160 .","journal-title":"Nat Rev Cardiol"},{"key":"353_CR13","author":"AR Pries","year":"2015","unstructured":"Pries AR, Badimon L, Bugiardini R, Camici PG, Dorobantu M, Duncker DJ, et al. Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Eur Heart J. 2015;. doi: 10.1093\/eurheartj\/ehv100 .","journal-title":"Eur Heart J"},{"issue":"6","key":"353_CR14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/dmrr.634","volume":"22","author":"E Cersosimo","year":"2006","unstructured":"Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22(6):423\u201336. doi: 10.1002\/dmrr.634 .","journal-title":"Diabetes Metab Res Rev"},{"issue":"9438","key":"353_CR15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937\u201352. doi: 10.1016\/S0140-6736(04)17018-9 .","journal-title":"Lancet"},{"issue":"6","key":"353_CR16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/01.CIR.101.6.676","volume":"101","author":"K Kuboki","year":"2000","unstructured":"Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation. 2000;101(6):676\u201381.","journal-title":"Circulation"},{"issue":"3","key":"353_CR17","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1172\/JCI117433","volume":"94","author":"HO Steinberg","year":"1994","unstructured":"Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94(3):1172\u20139. doi: 10.1172\/JCI117433 .","journal-title":"J Clin Invest"},{"issue":"4","key":"353_CR18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.ATV.0000209500.15801.4e","volume":"26","author":"Z He","year":"2006","unstructured":"He Z, Opland DM, Way KJ, Ueki K, Bodyak N, Kang PM, et al. Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K\/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol. 2006;26(4):787\u201393. doi: 10.1161\/01.ATV.0000209500.15801.4e .","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"353_CR19","author":"M Wigren","year":"2015","unstructured":"Wigren M, Rattik S, Hultman K, Bjorkbacka H, Nordin-Fredrikson G, Bengtsson E, et al. Decreased levels of stem cell factor in subjects with incident coronary events. J Intern Med. 2015;. doi: 10.1111\/joim.12443 .","journal-title":"J Intern Med"},{"issue":"11","key":"353_CR20","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.jacc.2004.08.062","volume":"44","author":"PO Bonetti","year":"2004","unstructured":"Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44(11):2137\u201341. doi: 10.1016\/j.jacc.2004.08.062 .","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"353_CR21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"4","key":"353_CR22","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9(4):e95192. doi: 10.1371\/journal.pone.0095192 .","journal-title":"PLoS One"},{"issue":"18","key":"353_CR23","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1093\/bioinformatics\/bth449","volume":"20","author":"JM Wettenhall","year":"2004","unstructured":"Wettenhall JM, Smyth GK. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics. 2004;20(18):3705\u20136. doi: 10.1093\/bioinformatics\/bth449 .","journal-title":"Bioinformatics"},{"issue":"3","key":"353_CR24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/18715273113126660154","volume":"13","author":"Z Mirza","year":"2014","unstructured":"Mirza Z, Kamal MA, Buzenadah AM, Al-Qahtani MH, Karim S. Establishing genomic\/transcriptomic links between Alzheimer\u2019s disease and type 2 diabetes mellitus by meta-analysis approach. CNS Neurol Disord Drug Targets. 2014;13(3):501\u201316.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"7","key":"353_CR25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.yexcr.2007.01.021","volume":"313","author":"E Rennel","year":"2007","unstructured":"Rennel E, Mellberg S, Dimberg A, Petersson L, Botling J, Ameur A, et al. Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. Exp Cell Res. 2007;313(7):1285\u201394. doi: 10.1016\/j.yexcr.2007.01.021 .","journal-title":"Exp Cell Res"},{"key":"353_CR26","doi-asserted-by":"crossref","first-page":"Article3","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3. doi: 10.2202\/1544-6115.1027 .","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"12","key":"353_CR27","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1469-8986.2011.01273.x","volume":"48","author":"DM Groppe","year":"2011","unstructured":"Groppe DM, Urbach TP, Kutas M. Mass univariate analysis of event-related brain potentials\/fields I: a critical tutorial review. Psychophysiology. 2011;48(12):1711\u201325. doi: 10.1111\/j.1469-8986.2011.01273.x .","journal-title":"Psychophysiology"},{"issue":"6","key":"353_CR28","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487\u201395.","journal-title":"Diabetes Care"},{"issue":"4","key":"353_CR29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jcmg.2011.12.014","volume":"5","author":"NP Johnson","year":"2012","unstructured":"Johnson NP, Gould KL. Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity. JACC Cardiovasc Imaging. 2012;5(4):430\u201340. doi: 10.1016\/j.jcmg.2011.12.014 .","journal-title":"JACC Cardiovasc Imaging"},{"key":"353_CR30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12933-015-0307-z","volume":"14","author":"MP Srinivasan","year":"2015","unstructured":"Srinivasan MP, Kamath PK, Bhat NM, Pai ND, Manjrekar PA, Mahabala C. Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10\u00a0years of duration: a case control study. Cardiovasc Diabetol. 2015;14:146. doi: 10.1186\/s12933-015-0307-z .","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"353_CR31","doi-asserted-by":"crossref","first-page":"e52036","DOI":"10.1371\/journal.pone.0052036","volume":"7","author":"KB Gast","year":"2012","unstructured":"Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One. 2012;7(12):e52036. doi: 10.1371\/journal.pone.0052036 .","journal-title":"PLoS One"},{"issue":"4 Pt 2","key":"353_CR32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.HYP.25.4.779","volume":"25","author":"A Grover","year":"1995","unstructured":"Grover A, Padginton C, Wilson MF, Sung BH, Izzo JL Jr, Dandona P. Insulin attenuates norepinephrine-induced venoconstriction. An ultrasonographic study. Hypertension. 1995;25(4 Pt 2):779\u201384.","journal-title":"Hypertension"},{"issue":"2","key":"353_CR33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.atherosclerosis.2010.03.013","volume":"211","author":"Y Chen","year":"2010","unstructured":"Chen Y, Osika W, Dangardt F, Gan LM, Strandvik B, Friberg P. High levels of soluble intercellular adhesion molecule-1, insulin resistance and saturated fatty acids are associated with endothelial dysfunction in healthy adolescents. Atherosclerosis. 2010;211(2):638\u201342. doi: 10.1016\/j.atherosclerosis.2010.03.013 .","journal-title":"Atherosclerosis"},{"issue":"1","key":"353_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00395-008-0760-x","volume":"104","author":"W Schaper","year":"2009","unstructured":"Schaper W. Collateral circulation: past and present. Basic Res Cardiol. 2009;104(1):5\u201321. doi: 10.1007\/s00395-008-0760-x .","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"353_CR35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cvr\/cvr161","volume":"92","author":"KL Kim","year":"2011","unstructured":"Kim KL, Meng Y, Kim JY, Baek EJ, Suh W. Direct and differential effects of stem cell factor on the neovascularization activity of endothelial progenitor cells. Cardiovasc Res. 2011;92(1):132\u201340. doi: 10.1093\/cvr\/cvr161 .","journal-title":"Cardiovasc Res"},{"issue":"10","key":"353_CR36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","volume":"92","author":"TT Rissanen","year":"2003","unstructured":"Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res. 2003;92(10):1098\u2013106. doi: 10.1161\/01.RES.0000073584.46059.E3 .","journal-title":"Circ Res"},{"issue":"2","key":"353_CR37","doi-asserted-by":"crossref","first-page":"F193","DOI":"10.1152\/ajprenal.2001.280.2.F193","volume":"280","author":"R Govers","year":"2001","unstructured":"Govers R, Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol. 2001;280(2):F193\u2013206.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"353_CR38","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2337\/db12-0354","volume":"62","author":"JS Bonner","year":"2013","unstructured":"Bonner JS, Lantier L, Hasenour CM, James FD, Bracy DP, Wasserman DH. Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance. Diabetes. 2013;62(2):572\u201380. doi: 10.2337\/db12-0354 .","journal-title":"Diabetes"},{"issue":"6","key":"353_CR39","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/MCB.18.6.3112","volume":"18","author":"I Stein","year":"1998","unstructured":"Stein I, Itin A, Einat P, Skaliter R, Grossman Z, Keshet E. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol. 1998;18(6):3112\u20139.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"353_CR40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molcel.2014.03.022","volume":"54","author":"E Karali","year":"2014","unstructured":"Karali E, Bellou S, Stellas D, Klinakis A, Murphy C, Fotsis T. VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress. Mol Cell. 2014;54(4):559\u201372. doi: 10.1016\/j.molcel.2014.03.022 .","journal-title":"Mol Cell"},{"issue":"15","key":"353_CR41","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/01.CIR.0000091339.70120.53","volume":"108","author":"A Festa","year":"2003","unstructured":"Festa A, Hanley AJ, Tracy RP, D\u2019Agostino R Jr, Haffner SM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation. 2003;108(15):1822\u201330. doi: 10.1161\/01.CIR.0000091339.70120.53 .","journal-title":"Circulation"},{"issue":"11","key":"353_CR42","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2010.09.074","volume":"57","author":"V Vaccarino","year":"2011","unstructured":"Vaccarino V, Khan D, Votaw J, Faber T, Veledar E, Jones DP, et al. Inflammation is related to coronary flow reserve detected by positron emission tomography in asymptomatic male twins. J Am Coll Cardiol. 2011;57(11):1271\u20139. doi: 10.1016\/j.jacc.2010.09.074 .","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"353_CR43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40618-014-0176-4","volume":"38","author":"G Filippo De","year":"2015","unstructured":"De Filippo G, Rendina D, Moccia F, Rocco V, Campanozzi A. Interleukin-6, soluble interleukin-6 receptor\/interleukin-6 complex and insulin resistance in obese children and adolescents. J Endocrinol Invest. 2015;38(3):339\u201343. doi: 10.1007\/s40618-014-0176-4 .","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"353_CR44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/HYPERTENSIONAHA.110.168245","volume":"58","author":"C Antoniades","year":"2011","unstructured":"Antoniades C, Demosthenous M, Tousoulis D, Antonopoulos AS, Vlachopoulos C, Toutouza M, et al. Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis. Hypertension. 2011;58(1):93\u20138. doi: 10.1161\/HYPERTENSIONAHA.110.168245 .","journal-title":"Hypertension"},{"issue":"6","key":"353_CR45","doi-asserted-by":"crossref","first-page":"R1013","DOI":"10.1152\/ajpregu.00729.2003","volume":"286","author":"JM Orshal","year":"2004","unstructured":"Orshal JM, Khalil RA. Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol. 2004;286(6):R1013\u201323. doi: 10.1152\/ajpregu.00729.2003 .","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"353_CR46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12933-016-0339-z","volume":"15","author":"L Ortega Moreno","year":"2016","unstructured":"Ortega Moreno L, Copetti M, Fontana A, De Bonis C, Salvemini L, Trischitta V, et al. Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes. Cardiovasc Diabetol. 2016;15(1):17. doi: 10.1186\/s12933-016-0339-z .","journal-title":"Cardiovasc Diabetol"},{"key":"353_CR47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12933-015-0184-5","volume":"14","author":"A Medina-Urrutia","year":"2015","unstructured":"Medina-Urrutia A, Posadas-Romero C, Posadas-Sanchez R, Jorge-Galarza E, Villarreal-Molina T, Gonzalez-Salazar Mdel C, et al. Role of adiponectin and free fatty acids on the association between abdominal visceral fat and insulin resistance. Cardiovasc Diabetol. 2015;14:20. doi: 10.1186\/s12933-015-0184-5 .","journal-title":"Cardiovasc Diabetol"},{"key":"353_CR48","doi-asserted-by":"crossref","first-page":"607364","DOI":"10.1155\/2015\/607364","volume":"2015","author":"YS Ding","year":"2015","unstructured":"Ding YS, Guo SX, Ma RL, Li SG, Guo H, Zhang JY, et al. Association of metabolic syndrome with the adiponectin to homeostasis model assessment of insulin resistance ratio. Mediators Inflamm. 2015;2015:607364. doi: 10.1155\/2015\/607364 .","journal-title":"Mediators Inflamm"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-016-0353-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T12:33:28Z","timestamp":1748781208000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cardiab.com\/content\/15\/1\/36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,19]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1186\/s12933-016-0353-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,19]]},"article-number":"36"}}